https://www.selleckchem.com/pr....oducts/piperaquine-p
This study was designed to evaluate the efficiency and safety of combination therapy with sodium-glucose cotransporter 2 (SGLT2) inhibitors and renin-angiotensin system blockers such as angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (AR in patients with type 2 diabetes mellitus (T2DM). We searched the PubMed, Embase, Web of Science and Cochrane Library databases from their inception to May 2020. Two authors independently performed study selection, risk-of-bias assessment and data extracti
Beğen
Yorum Yap
Paylaş
